BioCentury
ARTICLE | Financial News

Northwest Biotherapeutics completes direct public offering

April 21, 2014 7:00 AM UTC

Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md. Business: Cancer Date completed: 4/15/14 Type: Direct public offering Raised: $15 million Shares: 2.3 million Price: $6.60 Shares after offe...